Effectiveness and safety of dabigatran in Latin American patients with atrial fibrillation: Two years follow up results from GLORIA-AF registry — Sérgio Dubner (2020) | RDL Network
Effectiveness and safety of dabigatran in Latin American patients with atrial fibrillation: Two years follow up results from GLORIA-AF registry
Article 2020 en
Authors
SD
Sérgio Dubner
JS
José Francisco Kerr Saraiva
JF
Juan Carlos Núñez Fragoso
Abstract
1 min read
These regional data shows the sustained safety and effectiveness of dabigatran over two years of follow-up, consistent with already available evidence. An increase in accessibility and incorporation of NOAC to anticoagulant treatment strategies could potentially have a positive impact on AF stroke prevention in Latin America.
Christine Teutsch, Menno V. Huisman, Professor Gregory Lip, Hans‐Christoph Diener, Sérgio Dubner, Changsheng Ma, Kenneth J. Rothman, Kristina Zint, Amelie Elsaesser, Miney Paquette, Dorothee B. Bartels, Jonathan L. Halperin
Miney Paquette, Lionel Riou França, Christine Teutsch, Hans‐Christoph Diener, Shihai Lu, Sérgio Dubner, Chang Sheng, Kenneth J. Rothman, Kristina Zint, Jonathan L. Halperin, Brian Olshansky, Menno V. Huisman, Professor Gregory Lip, Robby Nieuwlaat
Discussion(0)
No comments yet. Be the first to comment.